MedPath

decrease of side effect of chemotherapy by continuous care model

Not Applicable
Conditions
Breast cancer.
Malignant neoplasm of Breast
C50.0, C50
Registration Number
IRCT2013070613802N2
Lead Sponsor
Ahvaz Jundishapor University Of Medical Sceinces
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
74
Inclusion Criteria

Being aware of the time and place; The lack of a clear and well-known sleep disorders, pain, fatigue, nausea and vomiting in the patient's medical history is mentioned; Lack of mental and brain diseases in the patient's medical history is mentioned (Thease has the effect of variables);The absence of severe dyspnea in patients; Not receiving the sleep-disrupting drugs such as diuretic drugs, antidepressants, and amphetamines and inotropes at night; Age 65-25 years; known Persian language; Patients who have a minimum of one and a maximum of 5 sessions of chemotherapy; Patients with stage II, III and IV disease.

Exclusion criteria:
Get an anesthetic and narcotic drugs during the study; Patient's unwillingness to continue participation in the study; Acute complications during the study; Get the sleep-disrupting drugs such as diuretic drugs, antidepressants, and amphetamines and inotropes at night; Need CPR during the intervention

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep quality. Timepoint: beginning of study, two months after intervention. Method of measurement: pittsburgh sleep quality Questionnaire.;Pain. Timepoint: beginning of study, two months after intervention. Method of measurement: pain assessment questionnaire.;Fatigue. Timepoint: beginning of study, two months after intervention. Method of measurement: fatigue summarized check list.;Nasea. Timepoint: beginning of study, two months after intervention. Method of measurement: nasea assessment questionnaire.;Body image. Timepoint: beginning of study, two months after intervention. Method of measurement: Body image scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath